Who won: Virachip system (RIPL Lab 01/150)

About this contract

This requirement is for the replacement of the existing Virachip system used by RIPL to carry out Lyme disease immunoblot testing for which RIPL acts as the frontline reference laboratory in England for this diagnostic service. The ViraChip platform uses a multiplex protein microarray containing the VlsE antigen together with multiple Borrelia-specific antigens. This enables simultaneous assessment of a broad antibody response rather than reliance on a single marker. The assay detects both IgM and IgG antibodies to Borrelia burgdorferi, supporting diagnosis across different stages of infection.

Who won contracts like this

• ✓Answer against the marking scheme, not the question text — UK Health Security Agency scores each response, so map your evidence to the published criteria and weightings.
• ✓At £51,480.37, expect quality and social value to carry a large share of the score — price alone rarely wins Detection and analysis apparatus work.
• ✓Show recent, comparable delivery: name similar Detection and analysis apparatus contracts you've delivered for public bodies, with measurable outcomes.
• ✓This one's been awarded — but UK Health Security Agency retenders on a cycle. Get matched the day the next one lands and start your draft early.

BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.

Related resources